The Ganglioside Ab IgM Panel test is primarily used to diagnose and monitor autoimmune neurological disorders such as Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). It helps detect IgM antibodies against gangliosides, assess peripheral nerve disorders, and provide insights into disease progression